Sex Differences in the Association Between AST/ALT and Incidence of Type 2 Diabetes in Japanese Patients with Nonalcoholic Fatty Liver Disease: A Retrospective Cohort Study

References

• The Lancet Gastroenterology Hepatology,The Lancet Gastroenterology & Hepatology: 5 years on.[J]. Lancet Gastroenterol Hepatol. 2021;6(9):677. doi:10.1016/S2468-1253(21)00268-5.
   PubMed Web of Science ®Google Scholar
• Sho I, Kohei O, Seiichi M, et al. Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD[J]. Mol Clin Oncol. 2022;16(2):55–62. doi:10.3892/mco.2021.2488.
   PubMed Web of Science ®Google Scholar
• Smith BW, Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.[J]. Nat Rev Endocrinol. 2011;7(8):456–465. doi:10.1038/nrendo.2011.72.
   PubMed Web of Science ®Google Scholar
• Ki-Chul S, Kim Sun H. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes.[j]. J Clin Endocrinol Metab. 2011;96(4):1093–1097. doi:10.1210/jc.2010-2190.
   PubMed Web of Science ®Google Scholar
• Tilg H, Adolph TE, Moschen AR. Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade. Hepatology. 2021;73(2):833–842. doi:10.1002/hep.31518.
   PubMed Web of Science ®Google Scholar
• Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005 May 2;115(5):1343–1351. doi:10.1172/JCI23621.
   PubMed Web of Science ®Google Scholar
• Santoleri D, Titchenell PM. Resolving the paradox of hepatic insulin resistance. Cell Mol Gastroenterol Hepatol. 2019;7(2):447–456. doi:10.1016/j.jcmgh.2018.10.016.
   PubMed Web of Science ®Google Scholar
• Afolabi BI, Ibitoye BO, Ikem RT, et al. The relationship between glycaemic control and non-alcoholic fatty liver disease in Nigerian type 2 diabetic patients.[J]. J Natl Med Assoc. 2018;110(3):256–264. doi:10.1016/j.jnma.2017.06.001.
   PubMed Web of Science ®Google Scholar
• Wen X, Zhou X, Chen D, Cheng J, Ji L. Association between non-alcoholic fatty liver disease and diabetes-related microvascular complications: a retrospective cross-sectional study of hospitalized patients. Endocr Pract. 2022;28(3):304–309. doi:10.1016/j.eprac.2021.02.004.
   PubMed Web of Science ®Google Scholar
• EI-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.[J]. Gastroenterology. 2004;126(2):460–468. doi:10.1053/j.gastro.2003.10.065.
   PubMed Web of Science ®Google Scholar
• Sadhna D, Mahadik Juhi D, Yaman T, May SB, Vierling JM. Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis.[J]. Pathology. 2022;54(6):686–693. doi:10.1016/j.pathol.2022.01.009.
   PubMed Web of Science ®Google Scholar
• Da T, Toyoda H, Toyoda H, et al. Utility of attenuation coefficient measurement using an ultrasound-guided attenuation parameter for evaluation of hepatic steatosis: comparison with MRI-determined proton density fat fraction.[J]. Am J Roentgenol. 2019;212(2):332–341. doi:10.2214/AJR.18.20123.
   PubMed Web of Science ®Google Scholar
• Dongiovanni P, Stender S, Pietrelli A, et al. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.[J]. J Intern Med. 2018;283(4):356–370. doi:10.1111/joim.12719.
   PubMed Web of Science ®Google Scholar
• Al Musaimi O, Abu-Nawwas AH, Al Shaer D, et al. Influence of age, gender, smoking, diabetes, thyroid and cardiac dysfunctions on cystatin C biomarker.[J]. Medicina de Familia SEMERGEN. 2019;45(1):44–51. doi:10.1016/j.semerg.2018.07.005.
   Google Scholar
• Yu-Han H, Chi C, Hye-Won L, et al. Influence of nonalcoholic fatty liver disease with Increased liver Enzyme Levels on the risk of cirrhosis and hepatocellular Carcinoma.[J]. Clin Gastroenterol Hepatol. 2022;21(4):960–969. doi:10.1016/j.cgh.2022.01.046.
   PubMed Web of Science ®Google Scholar
• Takahisa M, Kazuhiro Y, Tanno Y. Tanno Yuhei,Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke.[J]. Hepatol Int. 2022;16(1):81–88. doi:10.1007/s12072-021-10253-z.
   PubMed Web of Science ®Google Scholar
• Martha G-DR, Rodríguez-Morán M, Gómez-Díaz R, Wacher NH, Rodríguez-Hernández H, Guerrero-Romero F. Insulin resistance is associated with elevated transaminases and low aspartate aminotransferase/alanine aminotransferase ratio in young adults with normal weight.[J]. Eur J Gastroenterol Hepatol. 2017;29(4):435–440. doi:10.1097/MEG.0000000000000811.
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya LS, Samaranayake DL, VN AA, et al. Metabolic abnormalities in a cohort of overweight and obese children in an urban setting of Sri Lanka. Int J Endocrinol. 2021;2021:1–10. doi:10.1155/2021/9936889.
   Web of Science ®Google Scholar
• Jing X, Xiaomin S, Youjin P. The association of aspartate aminotransferase/alanine aminotransferase ratio with diabetic nephropathy in patients with type 2 diabetes.[J]. Diabetes Metab Syndr Obes. 2021;14:3831–3837. doi:10.2147/DMSO.S330741.
   PubMed Web of Science ®Google Scholar
• Le Michael H, Yee Hui Y, Xiaohe L, et al. Global NAFLD prevalence: a systematic review and meta-analysis.[J]. Clin Gastroenterol Hepatol. 2019;20(20):2809–2817. doi:10.1016/j.cgh.2021.12.002.
   Google Scholar
• Blandine T, Sarra S, Naia G, et al. Sex differences in metabolic regulation and diabetes susceptibility.[J]. Diabetologia. 2020;63(3):453–461. doi:10.1007/s00125-019-05040-3.
   PubMed Web of Science ®Google Scholar
• de Ritter Rianneke, Sep S, van der Kallen Carla J H, et al. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: the maastricht study.[J]. Cardiovasc Diabetol. 2021;20(1):102–216. doi:10.1186/s12933-021-01290-x.
   PubMed Web of Science ®Google Scholar
• Takuro O, Yoshitaka H, Masahide H, Obora A, Kojima T, Fukui M. Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study.[J]. IntJ Obes (Lond). 2019;43(1):139–148. doi:10.1038/s41366-018-0076-3.
   PubMed Web of Science ®Google Scholar
• Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. γ-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem. 2007;53(1):71–77. doi:10.1373/clinchem.2006.078980.
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36:S67–74.
   PubMed Web of Science ®Google Scholar
• Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082–1090. doi:10.1002/hep.24452.
   PubMed Web of Science ®Google Scholar
• Muzica CM, Sfarti C, Trifan A, et al. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: a bidirectional relationship. Can J Gastroenterol Hepatol. 2020;2020:1–5. doi:10.1155/2020/6638306.
   Web of Science ®Google Scholar
• Giovanni T, Felice C, Vito Concetta D, et al. Association of NAFLD and insulin resistance with non metastatic bladder cancer patients: a cross-sectional retrospective study.[J]. J Clin Med. 2021;10(2):346–356. doi:10.3390/jcm10020346.
   PubMed Web of Science ®Google Scholar
• Alexopoulos A-S, Crowley MJ, Wang Y, et al. G l y c e m i c control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease. Hepatology. 2021;74(3):1220–1233. doi:10.1002/hep.31806.
   PubMed Web of Science ®Google Scholar
• Adeva-Andany MM, Pérez-Felpete N, Fernández-Fernández C, Donapetry-García C, Pazos-García C. Liver glucose metabolism in humans. Biosci Rep. 2016;36(6):e00416. doi:10.1042/BSR20160385.
   PubMedGoogle Scholar
• Behnaz A, Seyed Hamid M, Fatemeh B, Zoghi G. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.[J]. BMC Gastroenterol. 2021;21(1):453. doi:10.1186/s12876-021-02038-3.
   PubMed Web of Science ®Google Scholar
• María M, Lide A, Migueles Jairo H, Rodríguez‐Vigil B, Ruiz JR, Labayen I. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.[J]. Pediatr Diabetes. 2020;21(4):565–574. doi:10.1111/pedi.13011.
   PubMed Web of Science ®Google Scholar
• De Ritis F, Coltorti M, Giusti G. An enzymic test for the diagnosis of viral hepatitis: the transaminase serum activities. 1957. Clin Chim Acta. 2006;369(2):148–152. doi:10.1016/j.cca.2006.05.001.
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Kohara K, Kusunoki T, Tabara Y, Abe M, Miki T. Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol. 2012;11(1):117. doi:10.1186/1475-2840-11-117.
   PubMedGoogle Scholar
• Visaria A, Pai S, Cheung M, Ahlawat S. Association between aspartate aminotransferase-to-alanine aminotransferase ratio and insulin resistance among US adults.[J]. Eur J Gastroenterol Hepatol. 2022;34(3):316–323. doi:10.1097/MEG.0000000000002215.
   PubMed Web of Science ®Google Scholar
• Sun-Hye K, Baeg Myong K, Kyung-Do H, et al. Increased liver markers are associated with higher risk of type 2 diabetes.[J]. World J Gastroenterol. 2015;21(24):7478–7487. doi:10.3748/wjg.v21.i24.7478.
   PubMed Web of Science ®Google Scholar
• Xia F, Hongya W, Xiaozhen T, Ye T, Xu Y, Fan J. Elevated serum regulator of calcineurin 2 is associated with an increased risk of non-alcoholic fatty liver Disease.[J]. Front Pharmacol. 2022;13:840764. doi:10.3389/fphar.2022.840764.
   PubMed Web of Science ®Google Scholar
• Felig P. The glucose-alanine cycle.[J]. Metabolism. 1973;22(2):179–207. doi:10.1016/0026-0495(73)90269-2.
   PubMed Web of Science ®Google Scholar
• Wei G, Hor-Yue T, Sha L, Wang N, Feng Y. Glutamic-pyruvic transaminase 1 facilitates alternative fuels for hepatocellular carcinoma growth—A small molecule inhibitor, Berberine. Cancers (Basel). 2020;12(7):1854–1871. doi:10.3390/cancers12071854.
   PubMed Web of Science ®Google Scholar
• Swarup S, Goyal A, Grigorova Y, Zeltser R. Metabolic syndrome.[J]. StatPearls. [Internet]. 2020. https://www.ncbi.nimnih.Gov/books/NBK459248/
   Google Scholar
• Marco D, Stefano M, Giacomo P, et al. Very low-carbohydrate ketogenic diet for the Treatment of Severe Obesity and associated non-alcoholic fatty liver disease: the role of sex Differences.[J]. Nutrients. 2020;12(9):2748–2761. doi:10.3390/nu12092748.
   PubMed Web of Science ®Google Scholar
• Mauvais-Jarvis F. Role of sex steroids in β cell function, growth, and survival.[J]. Trends Endocrinol Metab. 2016;27(12):844–855. doi:10.1016/j.tem.2016.08.008.
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocrine Rev. 2016;37(3):278–318. doi:10.1210/er.2015-1137.
   PubMed Web of Science ®Google Scholar
• Tramunt B, Smati S, Grandgeorge N, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020;63(3):453–461. doi:10.1007/s00125-019-05040-3.
   PubMed Web of Science ®Google Scholar
• Mera Jorge R, Beverly D, Mark F. Influence of gender on the ratio of serum aspartate aminotransferase (AST) to alanine aminotransferase (ALT) in patients with and without hyperbilirubinemia.[J]. Dig Dis Sci. 2008;53(3):799–802. doi:10.1007/s10620-007-9924-z.
   PubMed Web of Science ®Google Scholar
• Chen X, McClusky R, Itoh Y, Reue K, Arnold AP. X and Y chromosome complement influence adiposity and metabolism in mice.[J]. Endocrinology. 2013;154(3):1092–1104. doi:10.1210/en.2012-2098.
   PubMed Web of Science ®Google Scholar
• Ko SH, Baeg MK, Han KD, Ko SH, Ahn YB. Increased liver markers are associated with higher risk of type 2 diabetes. World J Gastroenterol. 2015;21(24):7478–7487. doi:10.3748/wjg.v21.i24.7478.
   PubMed Web of Science ®Google Scholar
• Shiqiang S, Lizhe L, Chao S, et al. Preoperative serum Gamma-Glutamyltransferase as a prognostic biomarker in patients undergoing radical cystectomy for bladder cancer.[j]. Front Oncol. 2021;11:648904. doi:10.3389/fonc.2021.648904.
   PubMed Web of Science ®Google Scholar
• Lee YS, Cho Y, Burgess S, et al. Serum gamma-glutamyl transferase and risk of type 2 diabetes in the general Korean population: a Mendelian randomization study.[j]. Hum Mol Genet. 2016;25(17):3877–3886. doi:10.1093/hmg/ddw226.
   PubMed Web of Science ®Google Scholar
• Jun-Hyuk L, Sun LH, Yong-Jae L. Serum γ-glutamyltransferase as an independent predictor for incident type 2 diabetes in middle-aged and older adults: findings from the KoGES over 12 years of follow-up.[j]. Nutr Metab Cardiovasc Dis. 2020;30(9):1484–1491. doi:10.1016/j.numecd.2020.04.027.
   PubMed Web of Science ®Google Scholar
• Ortega E, Koska J, Salbe AD, Ataranni PA T, Bunt JC. Serum γ-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in pima Indian children. The Journal Of Clinical Endocrinology & Metabolism. 2006;91(4):1419–1422. doi:10.1210/jc.2005-1783.
   PubMed Web of Science ®Google Scholar
• Jian W, Juan X, Xiaomin Y, et al. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.[j]. Clin Res Hepatol Gastroenterol. 2020;44(6):913–922. doi:10.1016/j.clinre.2020.01.011.
   PubMed Web of Science ®Google Scholar
• Gohel Mukesh G, Chacko Anusha N. Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control: an evidence linking oxidative stress, inflammation and glycemic control.[J]. J Diab Metab Disord. 2013;12(1):56. doi:10.1186/2251-6581-12-56.
   PubMedGoogle Scholar
• Matsuoka T, Kajimoto Y, Watada H, et al. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.[j]. J Clin Invest. 1997;99(1):144–150. doi:10.1172/JCI119126.
   PubMed Web of Science ®Google Scholar